Phenylacetic acid mustard is the primary metabolite of the chemotherapeutic agent chlorambucil and exhibits antitumor activity; it demonstrates 1.8–1.9 times greater antitumor potency than chlorambucil in vivo, with an ED15 value of 8.0 mg/kg; it shows in vivo anti-tumor efficacy in C3H/He mice following intraperitoneal administration.